These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7014053)

  • 21. Mineralocorticoids in normal pregnancy.
    Ehrlich EN; Nolten WE; Oparil S; Lindheimer MD
    Perspect Nephrol Hypertens; 1976; 5():189-201. PubMed ID: 63938
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adrenal mineralocorticoid function in sodium deficit with adequate or excess water consumption].
    Shul'ga VA
    Biull Eksp Biol Med; 1982 Apr; 93(4):89-91. PubMed ID: 7082812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
    Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Lichtwald K; Fiegel P
    Clin Sci (Lond); 1979 Nov; 57(5):409-14. PubMed ID: 519948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of steroids in urine for differentiation of pseudohypoaldosteronism and aldosterone biosynthetic defect.
    Honour JW; Dillon MJ; Shackleton CH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):325-31. PubMed ID: 7033278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of plasma endothelin-1 and aldosterone on sodium retention in children with nephrotic syndrome].
    Liu Z; Chen S; Wang Z; Wang Z; Mao M
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):320-2. PubMed ID: 10684103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aldosterone secretion, plasma renin activity and nephrotic syndromes in rats].
    Bloch R; De Nicola E; Desaulles E; Imbs JL; Velly J
    C R Seances Soc Biol Fil; 1967; 161(6):1411-5. PubMed ID: 4298667
    [No Abstract]   [Full Text] [Related]  

  • 28. [Various aspects of steroidogenesis in congenital adrenogenital syndrome with or without salt loss (determination of the urinary excretion of aldosterone, androsterone, etiocholanolone, dehydroisoandrosterone, 17-hydroxy-11-desoxycorticosterone, pregnanediol and pregnanetriol)].
    Cacciari E; Dallera L; Tassoni P; Cicognani A; Miano A
    Minerva Pediatr; 1969 May; 21(21):937-42. PubMed ID: 4247542
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Connell JM; Jardine AG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1526-32. PubMed ID: 23413088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
    Shimizu Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
    Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
    Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of the renin-angiotensin system in the pathogenesis of nephrotic syndrome].
    Kutyrina IM; Klepikov PV; Tareeva IE
    Ter Arkh; 1988; 60(6):32-4. PubMed ID: 3061050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children.
    Sonino N; Chow D; Levine LS; New MI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):31-9. PubMed ID: 7226574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
    Takeda Y; Miyamori I; Takeda R; Lewicka S; Vecsei P
    J Clin Endocrinol Metab; 1992 May; 74(5):1195-7. PubMed ID: 1569167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renin activity and aldosterone level in the plasma of children with lipoid nephrosis].
    Lao M; Bogoniowska Z; Wyszyńska T
    Pol Arch Med Wewn; 1990; 83(4-6):181-6. PubMed ID: 2251209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.
    Abdelhamid S; Müller-Lobeck H; Pahl S; Remberger K; Bönhof JA; Walb D; Röckel A
    Arch Intern Med; 1996 Jun; 156(11):1190-5. PubMed ID: 8639013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of potassium loading in normal man on dopaminergic control of mineralocorticoids and renin release.
    Witzgall H; Behr J
    J Hypertens; 1986 Apr; 4(2):201-5. PubMed ID: 3519763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of aldosterone and other mineralocorticoids].
    Shimizu N; Yoshida H
    Nihon Rinsho; 1976; 34 suppl():2132-46. PubMed ID: 792504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.